Stoke Therapeutics, Inc. (STOK)
33.92
+3.45
(+11.32%)
USD |
NASDAQ |
Dec 10, 15:28
Stoke Therapeutics Market Cap: 1.937B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 26.00B |
| Janux Therapeutics, Inc. | 942.52M |
| Insmed, Inc. | 40.91B |
| Sarepta Therapeutics, Inc. | 2.352B |
| Aldeyra Therapeutics, Inc. | 286.98M |
Market Cap Related Metrics
| PE Ratio | 51.40 |
| PS Ratio | 9.625 |
| Price to Book Value | 6.288 |
| Price to Free Cash Flow | 37.80 |
| Price | 33.92 |
| Earnings Yield | 1.95% |
| Operating PE Ratio | 72.78 |
| Normalized PE Ratio | 51.40 |